Madrigal Pharmaceuticals Inc. (MDGL) NASDAQ
$267.04 8.23 (3.18%)
Market Cap: $5.31B
As of 03/28/24 04:00 PM EDT. Market closed.
Madrigal Pharmaceuticals Inc. (MDGL)
NASDAQ
$267.04
8.23 (3.18%)
Market Cap: $5.31B
As of 03/28/24 04:00 PM EDT. Market closed.
madrigal pharmaceuticals inc. is a biotechnology company based out of calle laguna del marquesado nª 19, nave 16 edificio adriana 1ª planta, polígono industrial la resina (villaverde), madrid, community of madrid, ... read more
madrigal pharmaceuticals inc. is a biotechnology company based out of calle laguna del marquesado nª 19, nave 16 edificio adriana 1ª planta, polígono industrial la resina (villaverde), madrid, community of madrid, spain. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Lynch Brian Joseph | SVP and General Counsel | Jan 16, 2024 | Option Exercise | $243.92 | 949 | 231,480 | 14,052 | Jan 18, 2024, 01:52 PM |
FRIEDMAN PAUL A | Director | Jan 16, 2023 | Option Exercise | $243.92 | 2,254 | 549,796 | 20,001 | Jan 18, 2024, 01:47 PM |
Taub Rebecca | Pres., R&D, and CMO | Jan 16, 2024 | Option Exercise | $243.92 | 1,546 | 377,100 | 15,001 | Jan 18, 2024, 01:46 PM |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | Jan 16, 2024 | Option Exercise | $243.92 | 550 | 134,156 | 5,117 | Jan 18, 2024, 01:45 PM |
Howarth Alex G. | Chief Financial Officer | Jan 16, 2024 | Option Exercise | $243.92 | 1,067 | 260,263 | 13,934 | Jan 18, 2024, 01:39 PM |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | Dec 15, 2023 | Option Exercise | $87.92 | 2,000 | 175,840 | 7,667 | Dec 18, 2023, 04:30 PM |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | Dec 14, 2023 | Option Exercise | $87.92 | 2,000 | 175,840 | 7,667 | Dec 18, 2023, 04:30 PM |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | Dec 15, 2023 | Sale | $238.50 | 2,000 | 477,000 | 6,667 | Dec 18, 2023, 04:30 PM |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | Dec 14, 2023 | Sale | $232.50 | 2,000 | 465,000 | 6,667 | Dec 18, 2023, 04:30 PM |
BAKER BROS. ADVISORS LP | Director | Dec 13, 2023 | Buy | $219.39 | 81,159 | 17,805,684 | 1,774,294 | Dec 14, 2023, 06:10 PM |
BAKER BROS. ADVISORS LP | Director | Dec 14, 2023 | Buy | $228.32 | 20,633 | 4,710,893 | 1,793,403 | Dec 14, 2023, 06:10 PM |
BAKER BROS. ADVISORS LP | Director | Dec 12, 2023 | Buy | $218.31 | 34,578 | 7,548,616 | 1,699,129 | Dec 14, 2023, 06:09 PM |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | Dec 13, 2023 | Option Exercise | $87.92 | 2,500 | 219,800 | 8,167 | Dec 14, 2023, 04:30 PM |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | Dec 12, 2023 | Option Exercise | $87.92 | 1,300 | 114,296 | 6,967 | Dec 14, 2023, 04:30 PM |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | Dec 13, 2023 | Sale | $225.40 | 2,500 | 563,500 | 6,667 | Dec 14, 2023, 04:30 PM |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | Dec 12, 2023 | Sale | $217.85 | 1,300 | 283,200 | 6,467 | Dec 14, 2023, 04:30 PM |
Lynch Brian Joseph | SVP and General Counsel | Dec 05, 2023 | Option Exercise | $87.09 | 1,000 | 87,090 | 16,001 | Dec 06, 2023, 04:30 PM |
Lynch Brian Joseph | SVP and General Counsel | Dec 04, 2023 | Option Exercise | $81.16 | 1,800 | 146,090 | 16,801 | Dec 06, 2023, 04:30 PM |
Lynch Brian Joseph | SVP and General Counsel | Dec 04, 2023 | Sale | $218.87 | 1,800 | 393,964 | 16,001 | Dec 06, 2023, 04:30 PM |
Lynch Brian Joseph | SVP and General Counsel | Dec 05, 2023 | Sale | $227.33 | 1,000 | 227,330 | 15,001 | Dec 06, 2023, 04:30 PM |
Lynch Brian Joseph | SVP and General Counsel | Nov 29, 2023 | Option Exercise | $73.75 | 4,000 | 295,000 | 19,001 | Dec 01, 2023, 04:30 PM |
Lynch Brian Joseph | SVP and General Counsel | Nov 30, 2023 | Option Exercise | $73.75 | 3,000 | 221,250 | 18,001 | Dec 01, 2023, 04:30 PM |
Lynch Brian Joseph | SVP and General Counsel | Nov 30, 2023 | Sale | $204.58 | 3,000 | 613,730 | 17,001 | Dec 01, 2023, 04:30 PM |
Lynch Brian Joseph | SVP and General Counsel | Nov 29, 2023 | Sale | $199.19 | 4,000 | 796,750 | 18,001 | Dec 01, 2023, 04:30 PM |
BAKER BROS. ADVISORS LP | Director | Nov 21, 2023 | Buy | $188.47 | 64,350 | 12,128,340 | 1,667,104 | Nov 21, 2023, 06:15 PM |
BAKER BROS. ADVISORS LP | Director | Nov 20, 2023 | Buy | $185.74 | 20,709 | 3,846,575 | 1,607,668 | Nov 21, 2023, 06:14 PM |
BAKER BROS. ADVISORS LP | Director | Nov 17, 2023 | Buy | $174.70 | 46,370 | 8,100,704 | 1,588,541 | Nov 21, 2023, 06:14 PM |
BAKER BROS. ADVISORS LP | Director | Nov 14, 2023 | Buy | $156.42 | 34,188 | 5,347,837 | 1,531,757 | Nov 15, 2023, 05:13 PM |
BAKER BROS. ADVISORS LP | Director | Nov 15, 2023 | Buy | $161.97 | 15,199 | 2,461,721 | 1,545,775 | Nov 15, 2023, 05:13 PM |
BAKER BROS. ADVISORS LP | Director | Nov 14, 2023 | Buy | $154.00 | 37,660 | 5,799,653 | 1,500,227 | Nov 15, 2023, 05:12 PM |
BAKER BROS. ADVISORS LP | Director | Nov 13, 2023 | Buy | $143.21 | 69,839 | 10,001,368 | 1,465,494 | Nov 15, 2023, 05:12 PM |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | Mar 01, 2023 | Option Exercise | $87.92 | 5,000 | 439,600 | 10,667 | Mar 02, 2023, 04:30 PM |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | Feb 28, 2023 | Option Exercise | $87.92 | 5,000 | 439,600 | 10,667 | Mar 02, 2023, 04:30 PM |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | Mar 01, 2023 | Sale | $274.42 | 5,000 | 1,372,081 | 8,739 | Mar 02, 2023, 04:30 PM |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | Feb 28, 2023 | Sale | $272.07 | 5,000 | 1,360,357 | 9,767 | Mar 02, 2023, 04:30 PM |
Levy Richard S | Director | Jan 17, 2023 | Option Exercise | $103.02 | 22,489 | 2,316,844 | 31,589 | Jan 19, 2023, 07:57 PM |
Levy Richard S | Director | Jan 17, 2023 | Sale | $293.15 | 22,489 | 6,592,686 | 31,489 | Jan 19, 2023, 07:57 PM |
Lynch Brian Joseph | SVP and General Counsel | Jan 03, 2023 | Option Exercise | $91.79 | 13,000 | 1,193,270 | 13,000 | Jan 06, 2023, 09:08 AM |
Lynch Brian Joseph | SVP and General Counsel | Jan 03, 2023 | Sale | $282.92 | 13,000 | 3,677,977 | 12,400 | Jan 06, 2023, 09:08 AM |
Lynch Brian Joseph | SVP and General Counsel | Dec 23, 2022 | Option Exercise | $91.79 | 7,000 | 642,530 | 7,000 | Dec 28, 2022, 08:00 PM |
Lynch Brian Joseph | SVP and General Counsel | Dec 23, 2022 | Sale | $274.18 | 7,000 | 1,919,231 | 6,500 | Dec 28, 2022, 08:00 PM |
Sukhija Remy | Chief Commercial Officer | Dec 23, 2022 | Option Exercise | $60.26 | 30,000 | 1,807,800 | 30,000 | Dec 28, 2022, 08:00 PM |
Sukhija Remy | Chief Commercial Officer | Dec 23, 2022 | Sale | $274.14 | 30,000 | 8,224,073 | 29,407 | Dec 28, 2022, 08:00 PM |
BAY CITY CAPITAL LLC | 10% Owner | Aug 19, 2020 | Sale | $107.64 | 7,303 | 786,095 | 42,875 | Aug 19, 2020, 07:40 PM |
BAY CITY CAPITAL LLC | 10% Owner | Aug 18, 2020 | Sale | $110.03 | 10,197 | 1,121,976 | 50,178 | Aug 19, 2020, 07:40 PM |
BAY CITY CAPITAL LLC | 10% Owner | Aug 17, 2020 | Sale | $110.73 | 12,500 | 1,384,125 | 60,375 | Aug 19, 2020, 07:40 PM |
CRAVES FRED B | Director | Aug 19, 2020 | Sale | $107.64 | 7,303 | 786,095 | 42,875 | Aug 19, 2020, 07:40 PM |
CRAVES FRED B | Director | Aug 18, 2020 | Sale | $110.03 | 10,197 | 1,121,976 | 50,178 | Aug 19, 2020, 07:40 PM |
CRAVES FRED B | Director | Aug 17, 2020 | Sale | $110.73 | 12,500 | 1,384,125 | 60,375 | Aug 19, 2020, 07:40 PM |
MILLIGAN DAVID V | Director | Nov 19, 2018 | Sale | $131.60 | 10,000 | 1,316,000 | 20,000 | Feb 26, 2020, 06:06 PM |
MILLIGAN DAVID V | Director | Nov 21, 2018 | Sale | $112.54 | 20,000 | 2,250,800 | 0 | Feb 26, 2020, 05:41 PM |
BAY CITY CAPITAL LLC | 10% Owner | Dec 13, 2019 | Sale | $105.47 | 1,200,000 | 126,564,001 | 4,089,702 | Dec 13, 2019, 02:18 PM |
CRAVES FRED B | Director | Dec 13, 2019 | Sale | $105.47 | 1,200,000 | 126,564,001 | 4,089,702 | Dec 13, 2019, 02:08 PM |
CRAVES FRED B | Director | Jun 11, 2018 | Sale | $287.46 | 5,908 | 1,698,314 | 113,472 | Dec 13, 2019, 01:41 PM |
FRIEDMAN PAUL A | Chief Executive Officer | Nov 20, 2018 | Buy | $117.88 | 4,000 | 471,520 | 161,128 | Nov 23, 2018, 08:53 PM |
FRIEDMAN PAUL A | Chief Executive Officer | Nov 19, 2018 | Buy | $124.00 | 4,000 | 496,000 | 157,128 | Nov 19, 2018, 06:26 PM |
CRAVES FRED B | Director | Nov 19, 2018 | Buy | $124.69 | 2,000 | 249,387 | 298,067 | Nov 19, 2018, 06:09 PM |
MILLIGAN DAVID V | Director | Nov 14, 2018 | Option Exercise | $16.46 | 10,000 | 164,600 | 30,000 | Nov 14, 2018, 06:43 PM |
MILLIGAN DAVID V | Director | Sep 18, 2018 | Option Exercise | $9.45 | 20,000 | 189,000 | 20,000 | Sep 19, 2018, 04:25 PM |
Schneebaum Marc R | Chief Financial Officer | Jun 11, 2018 | Option Exercise | $86.64 | 7,957 | 689,409 | 51,767 | Jun 13, 2018, 03:53 PM |
Schneebaum Marc R | Chief Financial Officer | Jun 11, 2018 | Sale | $287.46 | 10,099 | 2,903,058 | 41,668 | Jun 13, 2018, 03:53 PM |
CRAVES FRED B | Director | Jun 11, 2018 | Sale | $287.46 | 280,000 | 80,488,798 | 5,264,382 | Jun 12, 2018, 09:02 PM |
FRIEDMAN PAUL A | Chief Executive Officer | Jun 11, 2018 | Sale | $287.46 | 73,526 | 21,135,783 | 655,540 | Jun 12, 2018, 08:56 PM |
Taub Rebecca | Chief Medical Officer, EVP R&D | Jun 11, 2018 | Sale | $287.46 | 73,526 | 21,135,783 | 655,540 | Jun 12, 2018, 08:55 PM |
BAY CITY CAPITAL LLC | Director | Jun 11, 2018 | Sale | $287.46 | 280,000 | 80,488,798 | 5,264,382 | Jun 12, 2018, 08:50 PM |
Levy Richard S | Director | Aug 23, 2017 | Buy | $16.12 | 2,000 | 32,236 | 9,100 | Aug 24, 2017, 04:04 PM |
Levy Richard S | Director | Aug 22, 2017 | Buy | $16.12 | 3,550 | 57,209 | 7,100 | Aug 23, 2017, 04:03 PM |
Levy Richard S | Director | Aug 21, 2017 | Buy | $15.88 | 3,550 | 56,358 | 3,550 | Aug 22, 2017, 04:05 PM |
Schor Chen | Former President and CEO | Jul 22, 2016 | Option Exercise | $9.48 | 14,250 | 135,090 | 37,178 | Jul 22, 2016, 05:23 PM |
Schneebaum Marc R | SVP and CFO | Jul 22, 2016 | Option Exercise | $9.48 | 8,548 | 81,035 | 19,308 | Jul 22, 2016, 05:22 PM |
Rieder Wendy E | Former SVP, Gen. Counsel | Jul 22, 2016 | Option Exercise | $9.48 | 8,550 | 81,054 | 17,730 | Jul 22, 2016, 05:18 PM |
Gollust Keith R | Director | Dec 14, 2015 | Sale | $0.32 | 300,000 | 96,690 | 1,539,169 | Dec 15, 2015, 04:34 PM |
Gollust Keith R | Director | Dec 11, 2015 | Sale | $0.37 | 300,000 | 111,030 | 1,839,169 | Dec 15, 2015, 04:34 PM |
Gollust Keith R | Director | Dec 09, 2015 | Sale | $0.38 | 145,892 | 55,235 | 2,139,169 | Dec 09, 2015, 05:00 PM |
Gollust Keith R | Director | Dec 08, 2015 | Sale | $0.38 | 300,000 | 114,060 | 2,285,061 | Dec 09, 2015, 05:00 PM |
Gollust Keith R | Director | Dec 07, 2015 | Sale | $0.39 | 300,000 | 115,830 | 2,585,061 | Dec 09, 2015, 05:00 PM |
Kovner Bruce | Director | Dec 04, 2015 | Sale | $0.41 | 97,978 | 40,406 | 1,474,236 | Dec 08, 2015, 02:09 PM |
Kovner Bruce | Director | Dec 08, 2015 | Sale | $0.37 | 496,015 | 183,526 | 340,970 | Dec 08, 2015, 02:09 PM |
Kovner Bruce | Director | Dec 08, 2015 | Sale | $0.37 | 873,624 | 323,241 | 600,548 | Dec 08, 2015, 02:09 PM |
Kovner Bruce | Director | Dec 07, 2015 | Sale | $0.41 | 36 | 15 | 836,985 | Dec 08, 2015, 02:09 PM |
Kovner Bruce | Director | Dec 07, 2015 | Sale | $0.41 | 64 | 26 | 1,474,172 | Dec 08, 2015, 02:09 PM |
Kovner Bruce | Director | Dec 04, 2015 | Sale | $0.41 | 55,629 | 22,941 | 837,021 | Dec 08, 2015, 02:09 PM |
Kovner Bruce | Director | Dec 01, 2015 | Sale | $0.43 | 306,625 | 131,910 | 2,178,196 | Dec 03, 2015, 05:49 PM |
Kovner Bruce | Director | Dec 03, 2015 | Sale | $0.41 | 95,040 | 39,337 | 892,650 | Dec 03, 2015, 05:49 PM |
Kovner Bruce | Director | Dec 03, 2015 | Sale | $0.41 | 167,394 | 69,284 | 1,572,214 | Dec 03, 2015, 05:49 PM |
Kovner Bruce | Director | Dec 02, 2015 | Sale | $0.43 | 249,015 | 106,379 | 987,690 | Dec 03, 2015, 05:49 PM |
Kovner Bruce | Director | Dec 02, 2015 | Sale | $0.43 | 438,588 | 187,365 | 1,739,608 | Dec 03, 2015, 05:49 PM |
Kovner Bruce | Director | Dec 01, 2015 | Sale | $0.43 | 174,091 | 74,894 | 1,236,705 | Dec 03, 2015, 05:49 PM |
Kovner Bruce | Director | Nov 25, 2015 | Sale | $0.49 | 959,149 | 468,161 | 3,489,499 | Nov 30, 2015, 05:23 PM |
Kovner Bruce | Director | Nov 30, 2015 | Sale | $0.43 | 231,959 | 100,554 | 1,410,796 | Nov 30, 2015, 05:23 PM |
Kovner Bruce | Director | Nov 30, 2015 | Sale | $0.43 | 408,546 | 177,105 | 2,484,821 | Nov 30, 2015, 05:23 PM |
Kovner Bruce | Director | Nov 27, 2015 | Sale | $0.50 | 338,463 | 167,539 | 1,642,755 | Nov 30, 2015, 05:23 PM |
Kovner Bruce | Director | Nov 27, 2015 | Sale | $0.50 | 596,132 | 295,085 | 2,893,367 | Nov 30, 2015, 05:23 PM |
Kovner Bruce | Director | Nov 25, 2015 | Sale | $0.49 | 544,571 | 265,805 | 1,981,218 | Nov 30, 2015, 05:23 PM |
Kovner Bruce | Director | Nov 23, 2015 | Sale | $0.44 | 405,324 | 177,086 | 4,791,894 | Nov 24, 2015, 05:27 PM |
Kovner Bruce | Director | Nov 24, 2015 | Sale | $0.44 | 194,883 | 86,002 | 2,525,789 | Nov 24, 2015, 05:27 PM |
Kovner Bruce | Director | Nov 24, 2015 | Sale | $0.44 | 343,246 | 151,474 | 4,448,648 | Nov 24, 2015, 05:27 PM |
Kovner Bruce | Director | Nov 23, 2015 | Sale | $0.44 | 230,129 | 100,543 | 2,720,672 | Nov 24, 2015, 05:27 PM |
Kovner Bruce | Director | Nov 18, 2015 | Sale | $0.43 | 108,154 | 46,820 | 992,953 | Nov 20, 2015, 05:42 PM |
Kovner Bruce | Director | Nov 20, 2015 | Sale | $0.44 | 83,397 | 36,953 | 2,950,801 | Nov 20, 2015, 05:42 PM |
Kovner Bruce | Director | Nov 20, 2015 | Sale | $0.44 | 146,886 | 65,085 | 5,197,218 | Nov 20, 2015, 05:42 PM |
Kovner Bruce | Director | Nov 19, 2015 | Sale | $0.46 | 65,802 | 30,381 | 3,034,198 | Nov 20, 2015, 05:42 PM |
Kovner Bruce | Director | Nov 19, 2015 | Sale | $0.46 | 115,896 | 53,509 | 5,344,104 | Nov 20, 2015, 05:42 PM |
Kovner Bruce | Director | Nov 19, 2015 | Sale | $0.50 | 992,953 | 501,441 | 0 | Nov 20, 2015, 05:42 PM |
Gollust Keith R | Director | Nov 17, 2015 | Sale | $0.41 | 100,000 | 41,400 | 2,885,061 | Nov 19, 2015, 06:03 PM |
Kovner Bruce | Director | Nov 17, 2015 | Sale | $0.42 | 700,618 | 295,661 | 1,101,107 | Nov 17, 2015, 05:08 PM |
Kovner Bruce | Director | Nov 16, 2015 | Sale | $0.44 | 15,530 | 6,759 | 1,801,725 | Nov 17, 2015, 05:08 PM |
Kovner Bruce | Director | Nov 13, 2015 | Sale | $0.43 | 507,788 | 219,568 | 1,817,255 | Nov 17, 2015, 05:08 PM |
Gollust Keith R | Director | Nov 10, 2015 | Sale | $0.55 | 188,322 | 103,050 | 2,985,061 | Nov 13, 2015, 11:20 AM |
Gollust Keith R | Director | Nov 10, 2015 | Sale | $0.55 | 188,322 | 103,050 | 2,985,061 | Nov 12, 2015, 06:00 PM |
Kovner Bruce | Director | Nov 12, 2015 | Sale | $0.47 | 733,564 | 347,783 | 2,325,043 | Nov 12, 2015, 05:19 PM |
Kovner Bruce | Director | Nov 11, 2015 | Sale | $0.50 | 1,080,941 | 538,201 | 3,058,607 | Nov 12, 2015, 05:19 PM |
Kovner Bruce | Director | Nov 10, 2015 | Sale | $0.55 | 1,397,114 | 769,111 | 4,139,548 | Nov 12, 2015, 05:19 PM |
Kovner Bruce | Director | Nov 09, 2015 | Sale | $0.61 | 2,225,054 | 1,354,168 | 5,536,662 | Nov 12, 2015, 05:19 PM |
Kovner Bruce | Director | Apr 06, 2015 | Buy | $1.75 | 6,857,143 | 12,000,000 | 15,278,610 | Apr 08, 2015, 04:21 PM |
Gollust Keith R | Director | Apr 06, 2015 | Buy | $1.75 | 350,000 | 612,500 | 3,173,383 | Apr 08, 2015, 04:18 PM |
WILSON ROBERT N | Director | Apr 06, 2015 | Buy | $1.75 | 50,000 | 87,500 | 754,118 | Apr 08, 2015, 04:16 PM |
Kovner Bruce | Director | Sep 30, 2014 | Buy | $3.08 | 300,000 | 923,130 | 8,421,467 | Oct 01, 2014, 01:56 PM |
Kovner Bruce | Director | Apr 11, 2014 | Buy | $4.01 | 1,250,000 | 5,012,500 | 8,121,467 | Apr 14, 2014, 07:34 PM |
Bernitz Steven B | SVP, Corporate Development | Dec 18, 2013 | Option Exercise | $0.00 | 25,000 | 2 | 25,000 | Dec 20, 2013, 04:23 PM |
Bahcall Safi R | President and CEO | Nov 13, 2013 | Buy | $3.75 | 20,000 | 75,000 | 2,053,135 | Nov 15, 2013, 06:03 PM |
REARDON WILLIAM S | Director | Nov 13, 2013 | Buy | $3.75 | 13,333 | 49,999 | 36,561 | Nov 15, 2013, 06:01 PM |
Gollust Keith R | Director | Nov 13, 2013 | Buy | $3.75 | 150,000 | 562,500 | 2,823,383 | Nov 15, 2013, 05:58 PM |
Kovner Bruce | Director | Nov 13, 2013 | Buy | $3.75 | 3,400,000 | 12,750,000 | 7,649,803 | Nov 15, 2013, 05:56 PM |
Kovner Bruce | Director | Nov 13, 2013 | Buy | $3.75 | 1,600,000 | 6,000,000 | 1,600,000 | Nov 15, 2013, 05:56 PM |
Kovner Bruce | Director | Jun 27, 2013 | Buy | $4.71 | 150,000 | 706,515 | 3,100,000 | Jul 01, 2013, 05:55 PM |
Bahcall Safi R | President and CEO | Jun 28, 2013 | Buy | $5.03 | 10,000 | 50,299 | 2,033,135 | Jul 01, 2013, 08:28 AM |
Kovner Bruce | Director | Jun 26, 2013 | Buy | $4.65 | 300,000 | 1,395,930 | 2,950,000 | Jun 27, 2013, 05:52 PM |
Kovner Bruce | Director | Jun 25, 2013 | Buy | $4.35 | 200,000 | 869,460 | 2,650,000 | Jun 27, 2013, 05:52 PM |
Kovner Bruce | Director | Jun 21, 2013 | Buy | $4.23 | 50,000 | 211,520 | 2,250,000 | Jun 25, 2013, 04:42 PM |
Kovner Bruce | Director | Jun 24, 2013 | Buy | $4.43 | 200,000 | 885,920 | 2,450,000 | Jun 25, 2013, 04:42 PM |
Bahcall Safi R | President and CEO | Jun 21, 2013 | Buy | $4.12 | 20,000 | 82,374 | 2,023,135 | Jun 24, 2013, 08:01 AM |
Kovner Bruce | Director | Jun 18, 2013 | Buy | $4.00 | 200,000 | 799,160 | 2,200,000 | Jun 20, 2013, 04:44 PM |
Bahcall Safi R | President and CEO | Jun 14, 2013 | Buy | $4.05 | 10,000 | 40,550 | 2,003,135 | Jun 17, 2013, 08:02 AM |
Bahcall Safi R | President and CEO | Jun 06, 2013 | Buy | $4.04 | 10,000 | 40,390 | 1,993,135 | Jun 06, 2013, 05:19 PM |
Kovner Bruce | Director | Jun 06, 2013 | Buy | $4.31 | 738,900 | 3,186,949 | 2,000,000 | Jun 06, 2013, 05:10 PM |
Kovner Bruce | Director | Jun 05, 2013 | Buy | $4.71 | 756,000 | 3,561,743 | 1,261,100 | Jun 06, 2013, 05:10 PM |
Kovner Bruce | Director | Jun 04, 2013 | Buy | $4.99 | 505,100 | 2,521,661 | 505,100 | Jun 06, 2013, 05:10 PM |
Vukovic Vojo | SVP, Chief Medical Officer | Jun 05, 2013 | Buy | $4.58 | 10,000 | 45,800 | 35,249 | Jun 06, 2013, 05:04 PM |
WILSON ROBERT N | Director | Jun 04, 2013 | Buy | $5.00 | 10,000 | 50,000 | 699,679 | Jun 06, 2013, 05:01 PM |
Ramachandra Sumant | President, R&D | Mar 11, 2013 | Option Exercise | $0.00 | 75,000 | 7 | 75,000 | Mar 13, 2013, 05:53 PM |
Gollust Keith R | Director | Jan 23, 2013 | Option Exercise | $8.66 | 114,250 | 989,603 | 316,255 | Jan 24, 2013, 04:59 PM |
WILSON ROBERT N | Director | Dec 12, 2012 | Option Exercise | $8.60 | 58,140 | 500,004 | 689,679 | Dec 14, 2012, 04:47 PM |
KUFE DONALD W | Director | Dec 12, 2012 | Option Exercise | $8.60 | 5,814 | 50,000 | 17,748 | Dec 14, 2012, 04:45 PM |
Kovner Bruce | Director | Dec 12, 2012 | Option Exercise | $8.60 | 2,325,581 | 19,999,997 | 3,273,281 | Dec 14, 2012, 04:43 PM |
Gollust Keith R | Director | Dec 12, 2012 | Option Exercise | $8.60 | 175,000 | 1,505,000 | 175,000 | Dec 14, 2012, 04:41 PM |
Gollust Keith R | Director | Dec 12, 2012 | Option Exercise | $8.60 | 75,000 | 645,000 | 2,673,383 | Dec 14, 2012, 04:41 PM |
Bahcall Safi R | President and CEO | Dec 12, 2012 | Option Exercise | $8.60 | 10,000 | 86,000 | 2,383,135 | Dec 14, 2012, 04:39 PM |
Singh Amar | Sr. VP, Chief Business Officer | Nov 29, 2012 | Option Exercise | $8.21 | 3,969 | 32,585 | 21,031 | Dec 03, 2012, 04:50 PM |
Kovner Bruce | Director | Nov 14, 2012 | Buy | $6.95 | 10,500 | 73,009 | 947,700 | Nov 14, 2012, 06:45 PM |
Kovner Bruce | Director | Nov 12, 2012 | Buy | $6.89 | 27,200 | 187,449 | 937,200 | Nov 14, 2012, 06:45 PM |
Bahcall Safi R | President and CEO | Nov 12, 2012 | Buy | $7.12 | 10,000 | 71,200 | 2,373,135 | Nov 13, 2012, 09:06 AM |
KUFE DONALD W | Director | Jul 25, 2012 | Option Exercise | $6.49 | 4,622 | 29,997 | 11,934 | Jul 27, 2012, 04:41 PM |
WILSON ROBERT N | Director | Jul 25, 2012 | Option Exercise | $6.49 | 100,000 | 649,000 | 631,539 | Jul 27, 2012, 04:40 PM |
Kovner Bruce | Director | Jul 25, 2012 | Option Exercise | $6.49 | 3,081,664 | 19,999,999 | 8,006,852 | Jul 27, 2012, 04:38 PM |
Gollust Keith R | Director | Jul 25, 2012 | Option Exercise | $6.49 | 770,416 | 5,000,000 | 2,598,383 | Jul 27, 2012, 04:36 PM |
Bahcall Safi R | President and CEO | Jul 25, 2012 | Option Exercise | $6.49 | 20,000 | 129,800 | 2,363,135 | Jul 27, 2012, 04:34 PM |
Kovner Bruce | Director | Jun 29, 2012 | Buy | $5.45 | 910,000 | 4,959,318 | 6,816,048 | Jul 02, 2012, 04:53 PM |
Gollust Keith R | Director | Jun 29, 2012 | Buy | $5.35 | 150,000 | 801,900 | 1,827,967 | Jul 02, 2012, 02:45 PM |
Vukovic Vojo | SVP, Chief Medical Officer | Jun 29, 2012 | Buy | $5.59 | 3,000 | 16,755 | 25,249 | Jul 02, 2012, 08:53 AM |
Bahcall Safi R | President and CEO | Jun 29, 2012 | Buy | $5.34 | 10,000 | 53,370 | 2,343,135 | Jul 02, 2012, 08:53 AM |
Rieder Wendy E | VP, IP and Legal, Gen. Counsel | Jun 18, 2012 | Option Exercise | $2.49 | 7,170 | 17,853 | 26,993 | Jun 20, 2012, 04:08 PM |
Rieder Wendy E | VP, IP and Legal, Gen. Counsel | Jun 18, 2012 | Sale | $6.00 | 7,170 | 43,020 | 19,823 | Jun 20, 2012, 04:08 PM |
Rieder Wendy E | VP, IP and Legal, Gen. Counsel | Jun 04, 2012 | Option Exercise | $2.49 | 7,170 | 17,853 | 26,993 | Jun 06, 2012, 04:23 PM |
Rieder Wendy E | VP, IP and Legal, Gen. Counsel | Jun 04, 2012 | Sale | $5.50 | 7,170 | 39,435 | 19,823 | Jun 06, 2012, 04:23 PM |
Vukovic Vojo | SVP, Chief Medical Officer | Mar 01, 2012 | Sale | $4.70 | 2,555 | 12,006 | 22,249 | Mar 05, 2012, 04:13 PM |
Koya Keizo | Sr. VP, Drug Development | Mar 01, 2012 | Sale | $4.70 | 6,844 | 32,187 | 12,999 | Mar 05, 2012, 04:12 PM |
Ehrlich Keith S | VP, Fin. and Admin., CFO | Mar 01, 2012 | Sale | $4.70 | 4,397 | 20,662 | 17,573 | Mar 05, 2012, 04:12 PM |
Kovner Bruce | Director | Jan 06, 2012 | Buy | $4.40 | 1,136,363 | 4,999,997 | 5,906,048 | Jan 10, 2012, 04:11 PM |
Kovner Bruce | Director | Dec 07, 2011 | Buy | $3.95 | 11,059 | 43,727 | 5,269,685 | Dec 09, 2011, 04:32 PM |
Kovner Bruce | Director | Nov 29, 2011 | Buy | $3.96 | 8,844 | 35,024 | 5,258,626 | Dec 01, 2011, 04:29 PM |
Kovner Bruce | Director | Nov 25, 2011 | Buy | $3.94 | 25,016 | 98,473 | 5,249,782 | Nov 29, 2011, 04:54 PM |
Kovner Bruce | Director | Nov 23, 2011 | Buy | $3.98 | 7,547 | 30,039 | 5,224,766 | Nov 25, 2011, 04:12 PM |
Kovner Bruce | Director | Nov 22, 2011 | Buy | $3.96 | 453 | 1,793 | 5,217,219 | Nov 25, 2011, 04:12 PM |
Kovner Bruce | Director | Nov 21, 2011 | Buy | $3.84 | 33,640 | 129,299 | 5,216,766 | Nov 22, 2011, 04:44 PM |
Kovner Bruce | Director | Nov 18, 2011 | Buy | $3.71 | 21,000 | 77,921 | 5,183,126 | Nov 22, 2011, 04:44 PM |
Kovner Bruce | Director | Sep 09, 2011 | Buy | $3.77 | 110,149 | 415,702 | 5,119,041 | Sep 13, 2011, 04:06 PM |
Kovner Bruce | Director | Sep 12, 2011 | Buy | $3.82 | 43,085 | 164,455 | 5,162,126 | Sep 13, 2011, 04:06 PM |
Kovner Bruce | Director | Sep 06, 2011 | Buy | $3.79 | 50,400 | 191,258 | 5,008,892 | Sep 07, 2011, 04:56 PM |
Kovner Bruce | Director | Sep 02, 2011 | Buy | $3.89 | 46,057 | 179,245 | 4,958,492 | Sep 07, 2011, 04:56 PM |
Vukovic Vojo | SVP, Chief Medical Officer | Sep 02, 2011 | Buy | $4.00 | 2,188 | 8,752 | 24,804 | Sep 06, 2011, 04:27 PM |
Vukovic Vojo | SVP, Chief Medical Officer | Sep 01, 2011 | Buy | $4.07 | 312 | 1,270 | 22,616 | Sep 06, 2011, 04:27 PM |
Kovner Bruce | Director | Aug 26, 2011 | Buy | $3.85 | 100 | 385 | 4,912,435 | Aug 30, 2011, 04:12 PM |
Kovner Bruce | Director | Aug 22, 2011 | Buy | $3.77 | 10,597 | 39,963 | 4,907,168 | Aug 24, 2011, 04:36 PM |
Kovner Bruce | Director | Aug 23, 2011 | Buy | $3.72 | 5,167 | 19,225 | 4,912,335 | Aug 24, 2011, 04:36 PM |
Kovner Bruce | Director | Aug 18, 2011 | Buy | $3.79 | 3,303 | 12,510 | 4,896,569 | Aug 22, 2011, 04:20 PM |
Kovner Bruce | Director | Aug 10, 2011 | Buy | $3.70 | 33,978 | 125,593 | 4,893,266 | Aug 10, 2011, 08:28 PM |
Kovner Bruce | Director | Aug 09, 2011 | Buy | $3.71 | 52,464 | 194,636 | 4,859,288 | Aug 10, 2011, 08:28 PM |
Kovner Bruce | Director | Aug 08, 2011 | Buy | $3.77 | 41,700 | 157,347 | 4,806,824 | Aug 10, 2011, 08:28 PM |
Koya Keizo | Sr. VP, Drug Development | Apr 20, 2011 | Sale | $5.60 | 10,000 | 56,000 | 29,843 | Apr 26, 2011, 09:44 PM |
Koya Keizo | Sr. VP, Drug Development | Apr 25, 2011 | Sale | $6.00 | 10,000 | 60,000 | 19,843 | Apr 26, 2011, 09:44 PM |
WILSON ROBERT N | Director | Apr 14, 2011 | Buy | $4.89 | 50,000 | 244,500 | 522,399 | Apr 18, 2011, 04:09 PM |
Gollust Keith R | Director | Apr 14, 2011 | Buy | $4.89 | 100,000 | 489,000 | 1,677,967 | Apr 18, 2011, 04:05 PM |
Kovner Bruce | Director | Apr 14, 2011 | Buy | $4.89 | 1,431,493 | 7,000,001 | 4,757,266 | Apr 18, 2011, 04:05 PM |
Bahcall Safi R | President and CEO | Mar 15, 2011 | Buy | $4.45 | 5,000 | 22,250 | 2,333,135 | Mar 15, 2011, 02:56 PM |
Vukovic Vojo | SVP, Chief Medical Officer | Mar 01, 2011 | Sale | $5.32 | 2,617 | 13,928 | 15,004 | Mar 03, 2011, 04:33 PM |
Rieder Wendy E | VP, IP and Legal, Gen. Counsel | Mar 01, 2011 | Sale | $5.25 | 5,284 | 27,762 | 15,426 | Mar 03, 2011, 04:30 PM |
Ehrlich Keith S | VP, Fin. and Admin., CFO | Mar 01, 2011 | Sale | $5.51 | 2,537 | 13,966 | 17,573 | Mar 03, 2011, 04:26 PM |
Koya Keizo | Sr. VP, Drug Development | Mar 01, 2011 | Sale | $5.23 | 18,270 | 95,552 | 32,999 | Mar 03, 2011, 04:20 PM |
Kovner Bruce | Director | Nov 10, 2010 | Option Exercise | $3.47 | 1,440,923 | 5,000,003 | 3,325,773 | Nov 12, 2010, 04:26 PM |
Kovner Bruce | Director | Sep 15, 2010 | Buy | $3.64 | 24,264 | 88,411 | 1,884,850 | Sep 17, 2010, 04:15 PM |
Kovner Bruce | Director | Sep 14, 2010 | Buy | $3.70 | 38,836 | 143,650 | 1,860,586 | Sep 15, 2010, 04:10 PM |
Kovner Bruce | Director | Sep 13, 2010 | Buy | $3.57 | 36,900 | 131,855 | 1,821,750 | Sep 15, 2010, 04:10 PM |
Vukovic Vojo | SVP, Chief Medical Officer | Aug 12, 2010 | Buy | $2.84 | 714 | 2,028 | 14,821 | Aug 20, 2010, 10:32 AM |
Vukovic Vojo | SVP, Chief Medical Officer | Aug 16, 2010 | Buy | $2.95 | 2,800 | 8,260 | 17,621 | Aug 20, 2010, 10:32 AM |
BAILEY MICHAEL P | Sr. VP, Chief Comm. Officer | Aug 05, 2010 | Sale | $3.21 | 4,000 | 12,840 | 29,627 | Aug 06, 2010, 04:41 PM |
Owner | Relationship | Date | Value($) |
Lynch Brian Joseph | SVP and General Counsel | 01/16/2024 | 231,480 |
FRIEDMAN PAUL A | Director | 01/16/2023 | 549,796 |
Taub Rebecca | Pres., R&D, and CMO | 01/16/2024 | 377,100 |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 01/16/2024 | 134,156 |
Howarth Alex G. | Chief Financial Officer | 01/16/2024 | 260,263 |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 12/15/2023 | 175,840 |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 12/14/2023 | 175,840 |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 12/15/2023 | 477,000 |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 12/14/2023 | 465,000 |
BAKER BROS. ADVISORS LP | Director | 12/13/2023 | 17,805,684 |
BAKER BROS. ADVISORS LP | Director | 12/14/2023 | 4,710,893 |
BAKER BROS. ADVISORS LP | Director | 12/12/2023 | 7,548,616 |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 12/13/2023 | 219,800 |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 12/12/2023 | 114,296 |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 12/13/2023 | 563,500 |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 12/12/2023 | 283,200 |
Lynch Brian Joseph | SVP and General Counsel | 12/05/2023 | 87,090 |
Lynch Brian Joseph | SVP and General Counsel | 12/04/2023 | 146,090 |
Lynch Brian Joseph | SVP and General Counsel | 12/04/2023 | 393,964 |
Lynch Brian Joseph | SVP and General Counsel | 12/05/2023 | 227,330 |
Lynch Brian Joseph | SVP and General Counsel | 11/29/2023 | 295,000 |
Lynch Brian Joseph | SVP and General Counsel | 11/30/2023 | 221,250 |
Lynch Brian Joseph | SVP and General Counsel | 11/30/2023 | 613,730 |
Lynch Brian Joseph | SVP and General Counsel | 11/29/2023 | 796,750 |
BAKER BROS. ADVISORS LP | Director | 11/21/2023 | 12,128,340 |
BAKER BROS. ADVISORS LP | Director | 11/20/2023 | 3,846,575 |
BAKER BROS. ADVISORS LP | Director | 11/17/2023 | 8,100,704 |
BAKER BROS. ADVISORS LP | Director | 11/14/2023 | 5,347,837 |
BAKER BROS. ADVISORS LP | Director | 11/15/2023 | 2,461,721 |
BAKER BROS. ADVISORS LP | Director | 11/14/2023 | 5,799,653 |
BAKER BROS. ADVISORS LP | Director | 11/13/2023 | 10,001,368 |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 03/01/2023 | 439,600 |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 02/28/2023 | 439,600 |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 03/01/2023 | 1,372,081 |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 02/28/2023 | 1,360,357 |
Levy Richard S | Director | 01/17/2023 | 2,316,844 |
Levy Richard S | Director | 01/17/2023 | 6,592,686 |
Lynch Brian Joseph | SVP and General Counsel | 01/03/2023 | 1,193,270 |
Lynch Brian Joseph | SVP and General Counsel | 01/03/2023 | 3,677,977 |
Lynch Brian Joseph | SVP and General Counsel | 12/23/2022 | 642,530 |
Lynch Brian Joseph | SVP and General Counsel | 12/23/2022 | 1,919,231 |
Sukhija Remy | Chief Commercial Officer | 12/23/2022 | 1,807,800 |
Sukhija Remy | Chief Commercial Officer | 12/23/2022 | 8,224,073 |
BAY CITY CAPITAL LLC | 10% Owner | 08/19/2020 | 786,095 |
BAY CITY CAPITAL LLC | 10% Owner | 08/18/2020 | 1,121,976 |
BAY CITY CAPITAL LLC | 10% Owner | 08/17/2020 | 1,384,125 |
CRAVES FRED B | Director | 08/19/2020 | 786,095 |
CRAVES FRED B | Director | 08/18/2020 | 1,121,976 |
CRAVES FRED B | Director | 08/17/2020 | 1,384,125 |
MILLIGAN DAVID V | Director | 11/19/2018 | 1,316,000 |
MILLIGAN DAVID V | Director | 11/21/2018 | 2,250,800 |
BAY CITY CAPITAL LLC | 10% Owner | 12/13/2019 | 126,564,001 |
CRAVES FRED B | Director | 12/13/2019 | 126,564,001 |
CRAVES FRED B | Director | 06/11/2018 | 1,698,314 |
FRIEDMAN PAUL A | Chief Executive Officer | 11/20/2018 | 471,520 |
FRIEDMAN PAUL A | Chief Executive Officer | 11/19/2018 | 496,000 |
CRAVES FRED B | Director | 11/19/2018 | 249,387 |
MILLIGAN DAVID V | Director | 11/14/2018 | 164,600 |
MILLIGAN DAVID V | Director | 09/18/2018 | 189,000 |
Schneebaum Marc R | Chief Financial Officer | 06/11/2018 | 689,409 |
Schneebaum Marc R | Chief Financial Officer | 06/11/2018 | 2,903,058 |
CRAVES FRED B | Director | 06/11/2018 | 80,488,798 |
FRIEDMAN PAUL A | Chief Executive Officer | 06/11/2018 | 21,135,783 |
Taub Rebecca | Chief Medical Officer, EVP R&D | 06/11/2018 | 21,135,783 |
BAY CITY CAPITAL LLC | Director | 06/11/2018 | 80,488,798 |
Levy Richard S | Director | 08/23/2017 | 32,236 |
Levy Richard S | Director | 08/22/2017 | 57,209 |
Levy Richard S | Director | 08/21/2017 | 56,358 |
Schor Chen | Former President and CEO | 07/22/2016 | 135,090 |
Schneebaum Marc R | SVP and CFO | 07/22/2016 | 81,035 |
Rieder Wendy E | Former SVP, Gen. Counsel | 07/22/2016 | 81,054 |
Gollust Keith R | Director | 12/14/2015 | 96,690 |
Gollust Keith R | Director | 12/11/2015 | 111,030 |
Gollust Keith R | Director | 12/09/2015 | 55,235 |
Gollust Keith R | Director | 12/08/2015 | 114,060 |
Gollust Keith R | Director | 12/07/2015 | 115,830 |
Kovner Bruce | Director | 12/04/2015 | 40,406 |
Kovner Bruce | Director | 12/08/2015 | 183,526 |
Kovner Bruce | Director | 12/08/2015 | 323,241 |
Kovner Bruce | Director | 12/07/2015 | 15 |
Kovner Bruce | Director | 12/07/2015 | 26 |
Kovner Bruce | Director | 12/04/2015 | 22,941 |
Kovner Bruce | Director | 12/01/2015 | 131,910 |
Kovner Bruce | Director | 12/03/2015 | 39,337 |
Kovner Bruce | Director | 12/03/2015 | 69,284 |
Kovner Bruce | Director | 12/02/2015 | 106,379 |
Kovner Bruce | Director | 12/02/2015 | 187,365 |
Kovner Bruce | Director | 12/01/2015 | 74,894 |
Kovner Bruce | Director | 11/25/2015 | 468,161 |
Kovner Bruce | Director | 11/30/2015 | 100,554 |
Kovner Bruce | Director | 11/30/2015 | 177,105 |
Kovner Bruce | Director | 11/27/2015 | 167,539 |
Kovner Bruce | Director | 11/27/2015 | 295,085 |
Kovner Bruce | Director | 11/25/2015 | 265,805 |
Kovner Bruce | Director | 11/23/2015 | 177,086 |
Kovner Bruce | Director | 11/24/2015 | 86,002 |
Kovner Bruce | Director | 11/24/2015 | 151,474 |
Kovner Bruce | Director | 11/23/2015 | 100,543 |
Kovner Bruce | Director | 11/18/2015 | 46,820 |
Kovner Bruce | Director | 11/20/2015 | 36,953 |
Kovner Bruce | Director | 11/20/2015 | 65,085 |
Kovner Bruce | Director | 11/19/2015 | 30,381 |
Kovner Bruce | Director | 11/19/2015 | 53,509 |
Kovner Bruce | Director | 11/19/2015 | 501,441 |
Gollust Keith R | Director | 11/17/2015 | 41,400 |
Kovner Bruce | Director | 11/17/2015 | 295,661 |
Kovner Bruce | Director | 11/16/2015 | 6,759 |
Kovner Bruce | Director | 11/13/2015 | 219,568 |
Gollust Keith R | Director | 11/10/2015 | 103,050 |
Gollust Keith R | Director | 11/10/2015 | 103,050 |
Kovner Bruce | Director | 11/12/2015 | 347,783 |
Kovner Bruce | Director | 11/11/2015 | 538,201 |
Kovner Bruce | Director | 11/10/2015 | 769,111 |
Kovner Bruce | Director | 11/09/2015 | 1,354,168 |
Kovner Bruce | Director | 04/06/2015 | 12,000,000 |
Gollust Keith R | Director | 04/06/2015 | 612,500 |
WILSON ROBERT N | Director | 04/06/2015 | 87,500 |
Kovner Bruce | Director | 09/30/2014 | 923,130 |
Kovner Bruce | Director | 04/11/2014 | 5,012,500 |
Bernitz Steven B | SVP, Corporate Development | 12/18/2013 | 2 |
Bahcall Safi R | President and CEO | 11/13/2013 | 75,000 |
REARDON WILLIAM S | Director | 11/13/2013 | 49,999 |
Gollust Keith R | Director | 11/13/2013 | 562,500 |
Kovner Bruce | Director | 11/13/2013 | 12,750,000 |
Kovner Bruce | Director | 11/13/2013 | 6,000,000 |
Kovner Bruce | Director | 06/27/2013 | 706,515 |
Bahcall Safi R | President and CEO | 06/28/2013 | 50,299 |
Kovner Bruce | Director | 06/26/2013 | 1,395,930 |
Kovner Bruce | Director | 06/25/2013 | 869,460 |
Kovner Bruce | Director | 06/21/2013 | 211,520 |
Kovner Bruce | Director | 06/24/2013 | 885,920 |
Bahcall Safi R | President and CEO | 06/21/2013 | 82,374 |
Kovner Bruce | Director | 06/18/2013 | 799,160 |
Bahcall Safi R | President and CEO | 06/14/2013 | 40,550 |
Bahcall Safi R | President and CEO | 06/06/2013 | 40,390 |
Kovner Bruce | Director | 06/06/2013 | 3,186,949 |
Kovner Bruce | Director | 06/05/2013 | 3,561,743 |
Kovner Bruce | Director | 06/04/2013 | 2,521,661 |
Vukovic Vojo | SVP, Chief Medical Officer | 06/05/2013 | 45,800 |
WILSON ROBERT N | Director | 06/04/2013 | 50,000 |
Ramachandra Sumant | President, R&D | 03/11/2013 | 7 |
Gollust Keith R | Director | 01/23/2013 | 989,603 |
WILSON ROBERT N | Director | 12/12/2012 | 500,004 |
KUFE DONALD W | Director | 12/12/2012 | 50,000 |
Kovner Bruce | Director | 12/12/2012 | 19,999,997 |
Gollust Keith R | Director | 12/12/2012 | 1,505,000 |
Gollust Keith R | Director | 12/12/2012 | 645,000 |
Bahcall Safi R | President and CEO | 12/12/2012 | 86,000 |
Singh Amar | Sr. VP, Chief Business Officer | 11/29/2012 | 32,585 |
Kovner Bruce | Director | 11/14/2012 | 73,009 |
Kovner Bruce | Director | 11/12/2012 | 187,449 |
Bahcall Safi R | President and CEO | 11/12/2012 | 71,200 |
KUFE DONALD W | Director | 07/25/2012 | 29,997 |
WILSON ROBERT N | Director | 07/25/2012 | 649,000 |
Kovner Bruce | Director | 07/25/2012 | 19,999,999 |
Gollust Keith R | Director | 07/25/2012 | 5,000,000 |
Bahcall Safi R | President and CEO | 07/25/2012 | 129,800 |
Kovner Bruce | Director | 06/29/2012 | 4,959,318 |
Gollust Keith R | Director | 06/29/2012 | 801,900 |
Vukovic Vojo | SVP, Chief Medical Officer | 06/29/2012 | 16,755 |
Bahcall Safi R | President and CEO | 06/29/2012 | 53,370 |
Rieder Wendy E | VP, IP and Legal, Gen. Counsel | 06/18/2012 | 17,853 |
Rieder Wendy E | VP, IP and Legal, Gen. Counsel | 06/18/2012 | 43,020 |
Rieder Wendy E | VP, IP and Legal, Gen. Counsel | 06/04/2012 | 17,853 |
Rieder Wendy E | VP, IP and Legal, Gen. Counsel | 06/04/2012 | 39,435 |
Vukovic Vojo | SVP, Chief Medical Officer | 03/01/2012 | 12,006 |
Koya Keizo | Sr. VP, Drug Development | 03/01/2012 | 32,187 |
Ehrlich Keith S | VP, Fin. and Admin., CFO | 03/01/2012 | 20,662 |
Kovner Bruce | Director | 01/06/2012 | 4,999,997 |
Kovner Bruce | Director | 12/07/2011 | 43,727 |
Kovner Bruce | Director | 11/29/2011 | 35,024 |
Kovner Bruce | Director | 11/25/2011 | 98,473 |
Kovner Bruce | Director | 11/23/2011 | 30,039 |
Kovner Bruce | Director | 11/22/2011 | 1,793 |
Kovner Bruce | Director | 11/21/2011 | 129,299 |
Kovner Bruce | Director | 11/18/2011 | 77,921 |
Kovner Bruce | Director | 09/09/2011 | 415,702 |
Kovner Bruce | Director | 09/12/2011 | 164,455 |
Kovner Bruce | Director | 09/06/2011 | 191,258 |
Kovner Bruce | Director | 09/02/2011 | 179,245 |
Vukovic Vojo | SVP, Chief Medical Officer | 09/02/2011 | 8,752 |
Vukovic Vojo | SVP, Chief Medical Officer | 09/01/2011 | 1,270 |
Kovner Bruce | Director | 08/26/2011 | 385 |
Kovner Bruce | Director | 08/22/2011 | 39,963 |
Kovner Bruce | Director | 08/23/2011 | 19,225 |
Kovner Bruce | Director | 08/18/2011 | 12,510 |
Kovner Bruce | Director | 08/10/2011 | 125,593 |
Kovner Bruce | Director | 08/09/2011 | 194,636 |
Kovner Bruce | Director | 08/08/2011 | 157,347 |
Koya Keizo | Sr. VP, Drug Development | 04/20/2011 | 56,000 |
Koya Keizo | Sr. VP, Drug Development | 04/25/2011 | 60,000 |
WILSON ROBERT N | Director | 04/14/2011 | 244,500 |
Gollust Keith R | Director | 04/14/2011 | 489,000 |
Kovner Bruce | Director | 04/14/2011 | 7,000,001 |
Bahcall Safi R | President and CEO | 03/15/2011 | 22,250 |
Vukovic Vojo | SVP, Chief Medical Officer | 03/01/2011 | 13,928 |
Rieder Wendy E | VP, IP and Legal, Gen. Counsel | 03/01/2011 | 27,762 |
Ehrlich Keith S | VP, Fin. and Admin., CFO | 03/01/2011 | 13,966 |
Koya Keizo | Sr. VP, Drug Development | 03/01/2011 | 95,552 |
Kovner Bruce | Director | 11/10/2010 | 5,000,003 |
Kovner Bruce | Director | 09/15/2010 | 88,411 |
Kovner Bruce | Director | 09/14/2010 | 143,650 |
Kovner Bruce | Director | 09/13/2010 | 131,855 |
Vukovic Vojo | SVP, Chief Medical Officer | 08/12/2010 | 2,028 |
Vukovic Vojo | SVP, Chief Medical Officer | 08/16/2010 | 8,260 |
BAILEY MICHAEL P | Sr. VP, Chief Comm. Officer | 08/05/2010 | 12,840 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BAKER BROS. ADVISORS LP | 2,070,544 | 6.02% | 5.11% | Other |
BLACKROCK INC. | 1,212,562 | 0.00715% | 17.41% | Other |
PAULSON & CO. INC. | 1,105,741 | 23.09% | 121.15% | Event Driven, Other |
GEODE CAPITAL MANAGEMENT, LLC | 336,255 | 0.00814% | 13.43% | Other |
ORBIMED ADVISORS LLC | 253,309 | 0.79% | Exited | Other |
RA CAPITAL MANAGEMENT, L.P. | 204,500 | 0.74% | No change | Other |
RENAISSANCE TECHNOLOGIES LLC | 68,082 | 0.02% | Exited | Other |
D. E. SHAW & CO., INC. | 34,500 (Call) | 0.00698% | 40.82% | Other |
CANDRIAM S.C.A. | 27,000 | 0.04% | -6.9% | Other |
BALYASNY ASSET MANAGEMENT L.P. | 28,204 | 0.0084% | Exited | Event Driven |
D. E. SHAW & CO., INC. | 15,622 | 0.00316% | 164.15% | Other |
AQR CAPITAL MANAGEMENT LLC | 6,113 | 0.00266% | -1.81% | Other |
TUDOR INVESTMENT CORP ET AL | 4,692 | 0.00687% | Exited | Event Driven, Other |
FARALLON CAPITAL MANAGEMENT LLC | 3,319 | 0.00381% | No change | Event Driven, Value |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,247 | 0.00533% | New | Other |
Period of Report: 12/31/2023
10-K/10-Q Filings: View